Cited by 2,089Pregnancy and preeclampsia studiesNeurological Complications and SyndromesBlood Pressure and Hypertension Studies

Hypertensive Disorders of Pregnancy: ISSHP Classification, Diagnosis, and Management Recommendations for International Practice

Open access
Brown, Mark A., Magee, Laura A., Kenny, Louise C., Karumanchi, S. Ananth, McCarthy, Fergus P., Saito, Shigeru, Hall, David R., Warren, Charlotte E. +2 more·2018·Hypertension

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/hypertensionaha.117.10803

Cites

116 of 116 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Data from the previously published CHIPS supports a target blood pressure goal of 110-135/85 mmHg to reduce the risk of uncontrolled maternal hypertension and minimize impaired fetal growth.

    “Data from the previously published Control of Hypertension in Pregnancy Study (CHIPS) supports a target blood pressure goal of 110-135/85 mmHg to reduce the risk of uncontrolled maternal hypertension and minimize impaired fetal growth (125-127).”

    From 15. Management of Diabetes in Pregnancy: <i>Standards of Care in Diabetes—2024</i> (2024) · cites this paper as [127]

    The CHIPS trial note (page unavailable) says targeting a diastolic BP of 85 mm Hg reduced accelerated maternal hypertension without a demonstrable adverse outcome for babies. But the paper recommends 110–140/85 mm Hg, not 110–135/85, and does not say that this target minimizes impaired fetal growth; it reports no demonstrable adverse outcome for babies. The Antenatal management section also describes the CHIPS tight-control target as 85 mm Hg diastolic and <160 mm Hg systolic. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • There is some evidence from randomized controlled trials that blood-pressure targets during pregnancy should range from 110 to 135 mmHg for systolic blood pressure and 80 to 85 mmHg for diastolic blood pressure.

    “There is some evidence from RCTs that BP targets during pregnancy should range from 110 to 135 mmHg for SBP and 80 to 85 mmHg for DBP.228”
  • The International Society for the Study of Hypertension in Pregnancy specifically recommends antihypertensive therapy to maintain systolic blood pressure between 110 and 140 mmHg and diastolic blood pressure between 80 and 85 mmHg.

    “A similar approach is supported by the International Society for the Study of Hypertension in Pregnancy, which speci fi cally recommends use of antihypertensive therapy to maintain systolic blood pressure between 110 and 140 mmHg and diastolic blood pressure between 80 and 85 mmHg (47).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Part of this paper’s reference list could not be split into single entries.

Flagged first, then by citations

Research works printed but not linked: 2

  1. Meher S, Duley L, Hunter K, Askie L. Antiplatelet therapy before or after 16 weeks'; gestation for preventing preeclampsia: an individual partici- pant data meta-analysis. Am J Obstet Gynecol. 2017;216:121.e2-128.e2.
  2. National Institute for Health and Clinical Excellence: Guidance. Hypertension in Pregnancy: The Management of Hypertensive Disorders During Pregnancy. London, UK: RCOG Press; 2010.

Cited by

Sorted by citations

Authors
Brown, M. A., Magee, L. A., Kenny, L. C., Karumanchi, S. A., McCarthy, F. P., Saito, S., Hall, D. R., Warren, C. E., Adoyi, G., & Ishaku, S.
Affiliations
  • UNSW Sydney (AU)
  • King's College London (GB)
  • University of Liverpool (GB)
  • Beth Israel Deaconess Medical Center (US)
  • Cork University Hospital (IE)
  • University of Toyama (JP)
  • Stellenbosch University (ZA)
  • Population Council (US)
  • Population Council (IN)
Venue
Hypertension
Published
2018-07
Volume
72
Issue
1
Pages
24-43
ISSN
  • 0194-911X (ISSN-L)
  • 1524-4563
OpenAlex
W2808237135
Cited by
2,089
References
116
Citations by year
2026: 219 · 2025: 273 · 2024: 269 · 2023: 336 · 2022: 341 · 2021: 297 · 2020: 210 · 2019: 112 · 2018: 23 · 2017: 4
FWCI
26.06
Type
journal article
Language
en
Open access
Locations
  • Hypertension (publishedVersion)
  • PubMed (publishedVersion)
  • Research Portal (King's College London) (submittedVersion, other-oa)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
  • Health Sciences › Medicine › Psychiatry and Mental health › Neurological Complications and Syndromes
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
Keywords
hypertensive disorders of pregnancy, preeclampsia, gestational hypertension, pregnancy complications
MeSH terms
Antihypertensive Agents, Female, Humans, Pregnancy, Blood Pressure Monitoring, Ambulatory, Disease Management, Hypertension, Pregnancy-Induced

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review